Natco targets drugs ripe for compulsory licensing Livemint According to the World Health Organization, India has an estimated 29000 liver and kidney cancer patients at whom Nexavar is targeted. An email sent on Wednesday to the Organisation of Pharmaceutical Producers of India, the body that represents ... |
